Clinical trial
Study to Evaluate an Influenza Vaccine Candidate
NCT00321373 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00321373 |
|---|---|
| Title | Study to Evaluate an Influenza Vaccine Candidate |
| Official title | A Study to Demonstrate the Non-Inferiority of Influenza Vaccine Candidate, Compared With Fluarix™ Administered Intramuscularly in Elderly Aged 60 Years Old and Above |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Candidate Influenza Vaccine GSK1247446A - 2 different formulations, FluarixTM |
| Enrollment | 1,220 |
| Start date | May 11, 2006 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 18, 2006 |
| First posted | May 3, 2006 |
| Last update posted | Jun 8, 2018 |
| Countries | Finland, Greece |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: